信星集團(01170.HK)料首財季銷售額按年降三成 利潤率下跌
信星集團(01170.HK)公布,集團預期於截至明年3月31日止財政年度第一季錄得銷售額較上年度同期下降約30%。預期利潤率亦將下降,主要歸因於收益減少及因此造成的勞工成本佔收益比例上升。
集團指,新型冠狀病毒已對全球零售業造成打擊,由於封鎖措施導致主要市場的商店暫停營業,同時減少對鞋履的需求,因而嚴重影響集團品牌客戶的業務。如公司早前年報所述,受疲弱的零售氣氛及新型冠狀病毒所影響,預期鞋履的銷售將拾級而下,品牌客戶將需時消化現有存貨,其後集團訂單方有反彈機會。因此,預期集團的業務將持續放緩,最少直至今年年底。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.